Vanda Pharma Announces U.S. Patent Allowance For PONVORY

(RTTNews) – The U.S. Patent and Trademark Office has issued a notice of allowance for Vanda Pharmaceuticals Inc.’s (VNDA) PONVORY (ponesimod) patent application, covering methods for reducing clinical management events before or during the treatment of multiple sclerosis and meth